Covid-19 | Russia authorises use of single dose vaccine Sputnik Light
The Hindu
Analysis of data after 28 days of administration of vaccine showed an efficacy of 79.4%.
Russia has authorised the use of Sputnik Light — a single dose vaccine against COVID-19. Sovereign wealth fund Russian Direct Investment Fund (RDIF) on Thursday said the move will pave way for the immunisation of a larger number of people in a shorter time frame. Sputnik Light is the first component — recombinant human adenovirus serotype number 26 (rAd26) — of Sputnik V vaccine that has been approved by over 60 countries, including India. CEO Kirill Dmitriev said that while the two-dose Sputnik V remains the main source of vaccination, Sputnik Light will be “exported to our international partners to help increase the rate of vaccinations in the face of the ongoing fight against the pandemic and new strains of coronavirus.” At less than $10, the vaccine will also be affordable, he said.More Related News
EU and Israel in war of words as ties nosedive ahead of Spain, Ireland recognizing Palestinian state
EU-Israel relations strained over Palestinian state recognition, with threats of sanctions and ICC involvement in conflict.